ArticleFrontiers in medicine2026
Trajectories of symptom burden and associated factors in patients with liver cirrhosis: a prospective study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Liver cirrhosis is frequently accompanied by multiple concurrent symptoms that cluster together, resulting in a high symptom burden and impairments in patients' quality of life and functional status. However, most existing studies rely on cross-sectional or static observational designs, which limit the exploration of the temporal sequence and potential causal relationships among symptoms. This study aimed to identify trajectories of symptom burden in patients with liver cirrhosis and to explore predictors of trajectory heterogeneity using latent class growth modeling (LCGM). Methods: A prospective longitudinal study was conducted from August 2023 to June 2024. A total of 223 hospitalized patients with liver cirrhosis were recruited from the Department of Infectious Diseases, a tertiary hospital in Zunyi, Guizhou Province, China, using convenience sampling. Data were collected at four time points-baseline (T₀, within 1 day of admission), 1 month (T₁), 3 months (T₂), and 6 months (T₃) after discharge-using a general information questionnaire and the Chinese version of the Memory Symptom Assessment Scale. Data were analyzed using SPSS 29.0 and Mplus 8.3. Results: Three distinct trajectories of symptom burden were identified: a high symptom-level risk group (C1, 12.56%), a moderate symptom-level decreasing group (C2, 36.32%), and a low symptom-level decreasing group (C3, 51.12%). Multinomial logistic regression analysis indicated that sex, average daily exercise duration, and Child-Pugh classification were significant predictors of trajectory membership ( Conclusion: The trajectories of symptom burden in patients with liver cirrhosis exhibit significant heterogeneity. Female sex, average daily exercise duration of less than 1 h, and Child-Pugh class C were associated with unfavorable symptom burden trajectories. Early identification of high-risk patients may help healthcare providers implement timely and targeted interventions to reduce symptom burden and improve clinical outcomes and quality of life.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.